Interpace Biosciences, Inc. SEC filings IDXG

Interpace Biosciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 6, 2003. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (results of operations). The company's fiscal year ends on December 31.

Interpace Biosciences, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Jul 7, 2026 —
DEF 14A Proxy statement Jul 7, 2026 Jul 7, 2026
PREM14A Filing Jun 25, 2026 Jun 24, 2026
PRE 14A Preliminary proxy statement Jun 23, 2026 Jun 23, 2026
DEFA14A Additional proxy material Sep 20, 2024 —
DEF 14A Proxy statement Sep 20, 2024 Sep 20, 2024
DEFA14A Additional proxy material Sep 22, 2023 —
DEF 14A Proxy statement Sep 22, 2023 Sep 22, 2023
DEFA14A Additional proxy material Sep 20, 2022 —
DEF 14A Proxy statement Sep 20, 2022 Sep 20, 2022
PRE 14A Preliminary proxy statement Sep 9, 2022 Sep 9, 2022
DEF 14A Proxy statement Sep 27, 2021 Sep 27, 2021
DEF 14A Proxy statement Jun 10, 2020 Jun 9, 2020
PRE 14A Preliminary proxy statement May 20, 2020 May 19, 2020
DEF 14A Proxy statement Nov 14, 2019 Nov 13, 2019
PRE 14A Preliminary proxy statement Nov 1, 2019 Nov 1, 2019
DEF 14A Proxy statement Aug 22, 2019 Aug 22, 2019
PRE 14A Preliminary proxy statement Aug 5, 2019 Aug 2, 2019
DEF 14A Proxy statement Apr 30, 2018 Apr 30, 2018
DEFA14A Additional proxy material Sep 13, 2017 —
DEFA14A Additional proxy material Aug 31, 2017 —
DEF 14A Proxy statement Aug 14, 2017 Aug 14, 2017
DEFA14A Additional proxy material Jul 25, 2016 —
DEFA14A Additional proxy material Jul 21, 2016 —
DEFA14A Additional proxy material Jul 11, 2016 —
DEFA14A Additional proxy material Jun 22, 2016 —
DEF 14A Proxy statement Jun 22, 2016 Aug 3, 2016
PRE 14A Preliminary proxy statement Jun 10, 2016 Jun 10, 2016
DEFA14A Additional proxy material Dec 22, 2015 —
DEFA14A Additional proxy material Dec 8, 2015 —
DEFA14A Additional proxy material Nov 23, 2015 —
DEFM14A Form defm14a Nov 23, 2015 —
DEFA14A Additional proxy material Nov 13, 2015 —
PREM14A Form prem14a Nov 12, 2015 Nov 12, 2015
DEFA14A Additional proxy material Nov 12, 2015 —
DEFA14A Additional proxy material Nov 2, 2015 —
DEFA14A Additional proxy material Nov 2, 2015 —
DEF 14A Proxy statement Apr 30, 2015 Jun 3, 2015
PRE 14A Preliminary proxy statement Apr 17, 2015 Jun 3, 2015
DEF 14A Proxy statement Apr 28, 2014 Jun 4, 2014
PRE 14A Preliminary proxy statement Apr 16, 2014 Jun 4, 2014
DEF 14A Proxy statement Apr 30, 2013 Jun 4, 2013
DEF 14A Proxy statement Apr 27, 2012 Jun 5, 2012
PRE 14A Preliminary proxy statement Apr 5, 2012 Jun 5, 2012
DEF 14A Proxy statement Apr 28, 2011 May 31, 2011
DEF 14A Proxy statement Apr 30, 2010 Jun 3, 2010
DEF 14A Proxy statement Apr 24, 2009 Jun 4, 2009
DEF 14A Proxy statement Apr 28, 2008 Jun 4, 2008
DEF 14A Proxy statement Apr 30, 2007 Jun 5, 2007
DEF 14A Proxy statement May 10, 2006 Jun 6, 2006
DEF 14A Proxy statement May 2, 2005 Jun 7, 2005
DEF 14A Proxy statement Apr 28, 2004 Jun 16, 2004

Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
IDXG (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Parsippany, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1054102
Former names
Interpace Diagnostics Group, Inc. (until Nov 1, 2019); PDI INC (until Dec 22, 2015); PROFESSIONAL DETAILING INC (until Nov 13, 2002)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.